GR3026204T3 - Optically active intermediate and production thereof - Google Patents

Optically active intermediate and production thereof

Info

Publication number
GR3026204T3
GR3026204T3 GR980400381T GR980400381T GR3026204T3 GR 3026204 T3 GR3026204 T3 GR 3026204T3 GR 980400381 T GR980400381 T GR 980400381T GR 980400381 T GR980400381 T GR 980400381T GR 3026204 T3 GR3026204 T3 GR 3026204T3
Authority
GR
Greece
Prior art keywords
optically active
production
represents hydrogen
active intermediate
cn2s
Prior art date
Application number
GR980400381T
Other languages
Greek (el)
English (en)
Inventor
Toshiro Konoike
Yoshitaka Araki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of GR3026204T3 publication Critical patent/GR3026204T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes
    • C07F9/5352Phosphoranes containing the structure P=C-
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
GR980400381T 1991-06-19 1998-02-25 Optically active intermediate and production thereof GR3026204T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17620991 1991-06-19
PCT/JP1992/000611 WO1992022560A1 (en) 1991-06-19 1992-05-14 Optically active intermediate and production thereof

Publications (1)

Publication Number Publication Date
GR3026204T3 true GR3026204T3 (en) 1998-05-29

Family

ID=16009533

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400381T GR3026204T3 (en) 1991-06-19 1998-02-25 Optically active intermediate and production thereof

Country Status (11)

Country Link
US (1) US5354879A (enrdf_load_stackoverflow)
EP (1) EP0554455B1 (enrdf_load_stackoverflow)
JP (2) JP3233403B2 (enrdf_load_stackoverflow)
KR (1) KR100216011B1 (enrdf_load_stackoverflow)
AT (1) ATE161262T1 (enrdf_load_stackoverflow)
DE (1) DE69223603T2 (enrdf_load_stackoverflow)
DK (1) DK0554455T3 (enrdf_load_stackoverflow)
ES (1) ES2110499T3 (enrdf_load_stackoverflow)
GR (1) GR3026204T3 (enrdf_load_stackoverflow)
TW (1) TW201730B (enrdf_load_stackoverflow)
WO (1) WO1992022560A1 (enrdf_load_stackoverflow)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3091022B2 (ja) 1992-07-16 2000-09-25 塩野義製薬株式会社 グルタル酸誘導体の製造方法
DE69424463T2 (de) * 1993-03-30 2000-09-14 Ube Industries, Ltd. Verfahren zur Herstellung von Ester-Derivaten der Oxyglutar-Säure
US5717124A (en) * 1993-03-30 1998-02-10 Ube Industries, Ltd. Process for preparation of oxyglutaric acid ester derivatives
US6376476B1 (en) * 1996-12-13 2002-04-23 Zymogenetics Corporation Isoprenoid pathway inhibitors for stimulating bone growth
US6121475A (en) * 1999-09-17 2000-09-19 Ube Industries, Ltd. Preparation of optically active β-hydroxyester derivatives and platinum-containing catalyst
KR100511533B1 (ko) * 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
GB0211751D0 (en) * 2002-05-22 2002-07-03 Avecia Ltd Compound and process
CA2537271A1 (en) * 2003-08-28 2005-03-17 Teva Pharmaceutical Industries, Ltd. Process for preparation of rosuvastatin calcium
WO2005051921A1 (en) 2003-11-24 2005-06-09 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
US7244844B2 (en) * 2003-12-02 2007-07-17 Teva Pharmaceutical Industries Ltd. Reference standard for characterization of rosuvastatin
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
JP2007508379A (ja) * 2004-07-13 2007-04-05 テバ ファーマシューティカル インダストリーズ リミティド Tempo媒介型酸化段階を包含するロスバスタチンの調製方法
CA2680693A1 (en) * 2005-02-22 2006-08-31 Teva Pharmaceutical Industries Ltd. Preparation of rosuvastatin
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
CA2619576C (en) * 2005-08-16 2011-12-06 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
CN1958593B (zh) * 2005-11-03 2010-05-05 上海医药工业研究院 一种用于合成瑞舒伐他汀钙的中间体的制备方法
WO2008130638A2 (en) 2007-04-18 2008-10-30 Teva Pharmaceutical Industries Ltd. A process for preparing intermediates of hmg-coa reductase inhibitors
EP2178846A1 (en) * 2007-07-12 2010-04-28 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and their preparation
US20110065920A1 (en) 2007-08-28 2011-03-17 Ratiopharm Gmbh Process for preparing pentanoic diacid derivatives
CN101735272B (zh) * 2009-12-11 2012-10-31 重庆博腾制药科技股份有限公司 瑞舒伐他汀钙中间体的制备方法
WO2013080219A2 (en) * 2011-11-28 2013-06-06 Mylan Laboratories Ltd NOVEL PROCESS FOR THE PREPARATION OF INTERMEDIATES OF HMG-CoA REDUCTASE INHIBITORS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421555A (en) * 1972-03-17 1976-01-21 Searle & Co Process for the stereoselective production of intermediates in the synthesis of pge1 and derivatives
US3907852A (en) * 1972-06-23 1975-09-23 Exxon Research Engineering Co Silylhydrocarbyl phosphines and related compounds
DE3722807A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
WO1989003212A1 (en) * 1987-10-13 1989-04-20 Pfizer Inc. 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
US4804770A (en) * 1988-04-29 1989-02-14 E. R. Squibb & Sons, Inc. Process for preparing a keto-phosphonate intermediate useful in preparing HMG-CoA reductase inhibitors
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
US5117039A (en) * 1988-12-14 1992-05-26 Shionogi & Co., Ltd. Monoesters of arylacetic acid and the process thereof
JP2719723B2 (ja) * 1988-12-14 1998-02-25 塩野義製薬株式会社 アリール酢酸モノエステル類およびその製造法
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives

Also Published As

Publication number Publication date
EP0554455B1 (en) 1997-12-17
US5354879A (en) 1994-10-11
ATE161262T1 (de) 1998-01-15
DE69223603D1 (de) 1998-01-29
EP0554455A4 (enrdf_load_stackoverflow) 1994-03-23
WO1992022560A1 (en) 1992-12-23
JP3233403B2 (ja) 2001-11-26
EP0554455A1 (en) 1993-08-11
ES2110499T3 (es) 1998-02-16
DE69223603T2 (de) 1998-04-09
JP3635247B2 (ja) 2005-04-06
KR100216011B1 (ko) 1999-08-16
DK0554455T3 (da) 1998-01-19
JP2002088054A (ja) 2002-03-27
KR930701460A (ko) 1993-06-11
TW201730B (enrdf_load_stackoverflow) 1993-03-11

Similar Documents

Publication Publication Date Title
GR3026204T3 (en) Optically active intermediate and production thereof
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
TW254943B (enrdf_load_stackoverflow)
TW255886B (enrdf_load_stackoverflow)
EP0573667A4 (enrdf_load_stackoverflow)
EP0443606A3 (en) 4-(4-alkoxyphenyl)-2-butylamine derivative and process therefor
AU689459B2 (en) Process for the preparation of aminotriazine derivatives
HUT52036A (en) Process for producing optically active amino-acides and theyr intermediates
EP0854135A3 (en) Process for preparing 2-cyanobiphenyl compound
AU644919B2 (en) Process for the production of (S)-vinyl and allenyl gaba
ES2033313T3 (es) Procedimiento de sintesis de azetidinonas.
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
AU4983293A (en) Optically active 1-phenylpyrrolidone derivative, intermediate for producing the same, and process for producing both
EP0441116A3 (en) Optically active chroman derivatives and intermediates thereof, and process for manufacturing same
HUT57757A (en) Process for producing dihydrofuranone derivatives
ES8404989A1 (es) Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.